Since age is the major risk factor for AD, we next exploited a recently published data-set of the ageing astrocyte translatome (10 weeks vs 24 months18) to ask whether changes induced in MAPTP301S and APP/PS1 astrocytes are enriched in those genes which change during normal ageing. This evidence concerns the gene PSEN1 and Alzheimer disease.